Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Profit Margin (Quarterly) : -93.21% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -93.21% |
| June 30, 2026 | -198.3% |
| March 31, 2026 | 6.48% |
| December 31, 2025 | -87.40% |
| September 30, 2025 | -425.2% |
| Date | Value |
|---|---|
| June 30, 2025 | -1.22K% |
| March 31, 2025 | -1.73K% |
| December 31, 2024 | -865.8% |
| September 30, 2024 | -5.67K% |
| June 30, 2024 | -32.23K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 19.60% |
| Johnson & Johnson | 0.83% |
| Merck & Co., Inc. | 27.96% |
| Bristol Myers Squibb Co. | 16.53% |
| ANI Pharmaceuticals, Inc. | 11.25% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.43% |
| Return on Assets | -20.41% |
| Return on Invested Capital | -23.00% |
| Gross Profit Margin (Quarterly) | 72.18% |
| Operating Margin (Quarterly) | -93.90% |
| Return on Net Operating Assets | -228.3% |